Review





Similar Products

protein fasta files against c neoformans var  (ATCC)
97
ATCC protein fasta files against c neoformans var
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Protein Fasta Files Against C Neoformans Var, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein fasta files against c neoformans var/product/ATCC
Average 97 stars, based on 1 article reviews
protein fasta files against c neoformans var - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
hi c fastq files  (Arima Genomics Inc)
99
Arima Genomics Inc hi c fastq files
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Hi C Fastq Files, supplied by Arima Genomics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hi c fastq files/product/Arima Genomics Inc
Average 99 stars, based on 1 article reviews
hi c fastq files - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
#10 c-pilot file  (VDW GmbH)
90
VDW GmbH #10 c-pilot file
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
#10 C Pilot File, supplied by VDW GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/#10 c-pilot file/product/VDW GmbH
Average 90 stars, based on 1 article reviews
#10 c-pilot file - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
#08 c + files  (Dentsply Sirona)
90
Dentsply Sirona #08 c + files
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
#08 C + Files, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/#08 c + files/product/Dentsply Sirona
Average 90 stars, based on 1 article reviews
#08 c + files - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
iso 10 file c-pilot  (VDW GmbH)
90
VDW GmbH iso 10 file c-pilot
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Iso 10 File C Pilot, supplied by VDW GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/iso 10 file c-pilot/product/VDW GmbH
Average 90 stars, based on 1 article reviews
iso 10 file c-pilot - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
c+ files #8  (Dentsply Sirona)
90
Dentsply Sirona c+ files #8
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
C+ Files #8, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c+ files #8/product/Dentsply Sirona
Average 90 stars, based on 1 article reviews
c+ files #8 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf  (Miyuki Giken Co Ltd)
90
Miyuki Giken Co Ltd file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
File Name C:\Users\Miyuki Yamaguchi\Documents\Nmrspectra For Publication\Publication22\Compound 3b\My2440 2 1 2nd Carbon 1 1.Jdf, supplied by Miyuki Giken Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf/product/Miyuki Giken Co Ltd
Average 90 stars, based on 1 article reviews
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf  (Miyuki Giken Co Ltd)
90
Miyuki Giken Co Ltd file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
File Name C:\Users\Miyuki Yamaguchi\Documents\Nmrspectra For Publication\Publication22\Compound 3a\As 135 1 Carbon 1 1.Jdf, supplied by Miyuki Giken Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf/product/Miyuki Giken Co Ltd
Average 90 stars, based on 1 article reviews
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
no. 10 c+ files  (Dentsply Sirona)
90
Dentsply Sirona no. 10 c+ files
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
No. 10 C+ Files, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/no. 10 c+ files/product/Dentsply Sirona
Average 90 stars, based on 1 article reviews
no. 10 c+ files - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Experimental workflow and proteome overview. A , murine infection model assay with C. neoformans -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).

Journal: Molecular & Cellular Proteomics : MCP

Article Title: Whole Blood Proteome Dynamics Defines Predictive Diagnostic and Prognostic Signatures of Cryptococcal Infection

doi: 10.1016/j.mcpro.2025.101083

Figure Lengend Snippet: Experimental workflow and proteome overview. A , murine infection model assay with C. neoformans -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).

Article Snippet: A comprehensive spectral library was generated using protein FASTA files against C. neoformans var. grubii serotype A (strain H99/ATCC 208821; UniProt UP000010091; 7429 sequences) and Mus musculus (17,836 Swiss-Prot reviewed entries, UniProt) ( ).

Techniques: Infection, Sample Prep, Control, Standard Deviation